Individuals deemed low risk for cardiotoxicity with HER2-directed antibody therapy developed modest incidences of treatment-related LVEF decline and heart failure across a large Western US hospital system

Cameron Smith1; David Page1; Michael Layoun; Li Hsin-Fang

Individuals deemed low risk for cardiotoxicity with HER2-directed antibody therapy developed modest incidences of treatment-related LVEF decline and heart failure across a large Western US hospital system

Cameron Smith1
, David Page1
, Michael Layoun
, Li Hsin-Fang

Research output: Other contribution

Original language	Undefined/Unknown
State	Published - Apr 29 2026

Publication series

Name	Books, Presentations, Posters, Etc.

Access to Document

http://digitalcommons.providence.org/other_pubs/180

Cite this

@misc{469d955b82794b86bd4c27e845754dd3,

title = "Individuals deemed low risk for cardiotoxicity with HER2-directed antibody therapy developed modest incidences of treatment-related LVEF decline and heart failure across a large Western US hospital system",

author = "Cameron Smith1 and David Page1 and Michael Layoun and Li Hsin-Fang",

year = "2026",

month = apr,

day = "29",

language = "Undefined/Unknown",

series = "Books, Presentations, Posters, Etc.",

type = "Other",

}

TY - GEN

T1 - Individuals deemed low risk for cardiotoxicity with HER2-directed antibody therapy developed modest incidences of treatment-related LVEF decline and heart failure across a large Western US hospital system

AU - Smith1, Cameron

AU - Page1, David

AU - Layoun, Michael

AU - Hsin-Fang, Li

PY - 2026/4/29

Y1 - 2026/4/29

M3 - Other contribution

T3 - Books, Presentations, Posters, Etc.

ER -